AQR Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$761K Buy
21,407
+3,779
+21% +$149K ﹤0.01% 3224
2026
Q2
$818K Sell
17,628
-16,751
-49% -$603K ﹤0.01% 3117
2026
Q1
$843K Buy
34,379
+7,152
+26% +$169K ﹤0.01% 2868
2025
Q4
$676K Buy
27,227
+5,640
+26% +$150K ﹤0.01% 2765
2025
Q3
$612K Buy
+21,587
New +$585K ﹤0.01% 2707
2025
Q2
– Sell
-30,082
Closed -$933K – 3410
2025
Q1
$933K Buy
+30,082
New +$1M ﹤0.01% 2065
2022
Q4
– Sell
-6,314
Closed -$246K – 2294
2022
Q3
$246K Sell
6,314
-1,815
-22% -$83.1K ﹤0.01% 1996
2022
Q2
$314K Buy
8,129
+1,713
+27% +$65.2K ﹤0.01% 1849
2022
Q1
$311K Sell
6,416
-5,521
-46% -$285K ﹤0.01% 1955
2021
Q4
$877K Hold
11,937
– – ﹤0.01% 1610
2021
Q3
$1.09M Buy
+11,937
New +$1.02M ﹤0.01% 1492

Other funds holding ASTH

AQR Capital Management's ASTH Position: Q3 2026 in Review

AQR Capital Management increased its Astrana Health (ASTH) stake by 21% in Q3 2026, buying an estimated $149K and bringing the position to 21,407 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #3224.

AQR Capital Management first reported a position in ASTH in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.09M in Q3 2021. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • AQR Capital Management held 21,407 shares of Astrana Health worth $761K as of Q3 2026.
  • AQR Capital Management bought 3,779 Astrana Health shares in Q3 2026, an estimated $149K.
  • Astrana Health made up ﹤0.01% of AQR Capital Management's portfolio in Q3 2026, its #3224 holding.
  • AQR Capital Management first reported a position in Astrana Health in Q3 2021 and has held it in 11 quarters since.
  • AQR Capital Management's Astrana Health position peaked at $1.09M in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.